多发性骨髓瘤的免疫微环境研究进展
摘要
关键词
全文:
PDF参考
[1]MaNing,LiuHuihui,ZhangYangetal.IdentificationofCD8T-cellepitopefrommultiplemyeloma-specificantigenAKAP4.[J].FrontImmunol,2022,13:927804.[2]ZambelloR,BarilàG,ManniS,etal.NKcellsandCD38:Implicationfor(Immuno)TherapyinPlasmaCellDyscrasias[J].Cells,2020,9(3):768.[3]KeruakousAR,AschA,AljumailyR,etal.Prognosticimpactofnaturalkillercellrecoveryonminimalresidualdiseaseafterautologousstemcelltransplantationinmultiplemyeloma[J].TransplImmunol,2022,71(1):101544.[4]EhlersFemkeAI,MahaweniNikenM,vandeWaterwegBerendsAnnetetal.ExploringthepotentialofcombiningIL-2-activatedNKcellswithananti-PDL1monoclonalantibodytotargetmultiplemyeloma-associatedmacrophages.[J].CancerImmunolImmunother,2023,72:1789-1801.[5]李珂颖,郝振华.Tfh细胞和Tfr细胞的免疫平衡在自身免疫性疾病中的研究进展[J].医学综述,2019,25(23):4657-4661.
DOI: http://dx.doi.org/10.12361/2661-3603-06-02-156134
Refbacks
- 当前没有refback。